Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead

As great of an investment as Eli Lilly (NYSE: LLY) is during the age of Zepbound, its newest and hottest weight-loss drug, there are many other magnificent opportunities out there right now, and it'd be a disservice to your portfolio to ignore them entirely. Take Iovance Biotherapeutics (NASDAQ:…#elililly #lly #zepbound #iovance #fda #nsclc #atc #alexcarchidi #motleyfool #forgetelililly
Source: Reuters: Health - Category: Consumer Health News Source Type: news